Soiza Roy L, Cumming Kirsten, Clarke Jennifer M, Wood Karen M, Myint Phyo K
Department of Medicine for the Elderly, NHS Grampian, c/o Wards 303/4, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, UK.
School of Medicine & Dentistry, University of Aberdeen, Aberdeen AB25 2ZD, UK.
J Clin Med. 2014 Aug 18;3(3):944-58. doi: 10.3390/jcm3030944.
Hyponatremia is especially common in older people. Recent evidence highlights that even mild, chronic hyponatremia can lead to cognitive impairment, falls and fractures, the latter being in part due to bone demineralization and reduced bone quality. Hyponatremia is therefore of special significance in frail older people. Management of hyponatremia in elderly individuals is particularly challenging. The underlying cause is often multi-factorial, a clear history may be difficult to obtain and clinical examination is unreliable. Established treatment modalities are often ineffective and carry considerable risks, especially if the diagnosis of underlying causes is incorrect. Nevertheless, there is some evidence that correction of hyponatremia can improve cognitive performance and postural balance, potentially minimizing the risk of falls and fractures. Oral vasopressin receptor antagonists (vaptans) are a promising innovation, but evidence of their safety and effect on important clinical outcomes in frail elderly individuals is limited.
低钠血症在老年人中尤为常见。最近的证据表明,即使是轻度慢性低钠血症也会导致认知障碍、跌倒和骨折,后者部分归因于骨质脱矿和骨质量下降。因此,低钠血症在体弱的老年人中具有特殊意义。老年个体低钠血症的管理极具挑战性。潜在病因往往是多因素的,可能难以获得清晰的病史,临床检查也不可靠。既定的治疗方式往往无效且存在相当大的风险,尤其是在潜在病因诊断错误的情况下。然而,有证据表明纠正低钠血症可改善认知能力和姿势平衡,有可能将跌倒和骨折风险降至最低。口服血管加压素受体拮抗剂(托伐普坦类药物)是一项有前景的创新,但关于其在体弱老年个体中的安全性及对重要临床结局影响的证据有限。